This startup seeks to replace surgery with its endometriosis test

The latest stories trending on MedCity News.

Editor's Pick

Top Story How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes. Sponsored 5 Companies That Offer Mobile IV Therapy With Experienced Nurses in NYC and Beyond Presented by IV Elements Get your IV treatment from wherever you are. These top companies provide mobile IV therapy administered by experienced nurses in NYC and beyond. Learn More.

Featured News

BMS Buys Into BioNTech Bispecific Antibody, Putting Up $1.5B to Collaborate in Multiple Cancers Bristol Myers Squibb's partnership with BioNTech makes it the third big pharma company to strike a deal to gain access to a PD-L1/PD-1 and VEGF bispecific antibody with potential use in drug combinations to treat cancer. The deal calls for the two companies to share in the development of BioNTech's drug and co-commercialize the asset globally. Wisp Unveils Diagnostics Arm Wisp is now offering at-home testing for Chlamydia, Gonorrhea, Trichomaniasis and Mycoplasma Genitalium. A Defining Moment for Employer Health Benefits: How the "One Big Beautiful Bill" Could Transform Healthcare for Employers The "One Big Beautiful Bill" would codify Individual Coverage Health Reimbursement Arrangements (ICHRAs) — the personalized insurance model that has transformed how employers offer health benefits — into law as CHOICE Arrangements, or Custom Health Option and Individual Care Expense arrangements.   HIPAA's Blind Spot: It's Time to Address Client-Side Attacks The bottom line is that while recognizing there is an issue is vital, too many healthcare organizations are counting on solutions that cannot and will not provide a sufficient line of defense.

Video   How employers are managing GLP-1s At MedCity INVEST, Shawn Gremminger, president and CEO of the National Alliance of Healthcare Purchaser Coalitions, discussed the strategies he's seeing employers implement around GLP-1s. He noted that many employers are taking a "middle ground" approach—such as covering the drugs for individuals with higher BMIs—and are also providing lifestyle support.

Sponsored The 6 Most Affordable Workflow Optimization Tools for Radiology Presented by Candelis Radiologists today face a surge in imaging volume and pressure to produce fast, accurate reports. Workflow optimization is about delivering the right results at the right time with less friction. Learn More

Resources

MedCity Pivot Podcast: Precision Medicine with the CEO of Helix In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe